Dr. Partha Basu is head of the Cancer Early Detection, Prevention & Infections Branch at the International Agency for Research on Cancer based in Lyon, France. His research has been instrumental to recent events that will promote equity in preventing cervical cancer, such as WHO concluding that a single dose of HPV vaccine delivers solid protection, authorities recommending marketing authorization for a new low-cost HPV vaccine in India and WHO recommending a simple and affordable technology (thermal ablation) for treatment of cervical precancers. Evidence generated from his study on the long-term impact of triennial screening for breast cancer with clinical breast examination (CBE) will be very valuable for the WHO’s global breast cancer initiative. Dr. Basu has been supporting countries across the globe to implement cancer screening programmes with equity and quality through the project named Cancer Screening in Five Continents (CanScreen5). He is leading implementation research projects aiming at improving cancer early detection in socio-economically disadvantaged populations in three countries in Europe and in India. He has significantly contributed to build capacity in delivering quality assured cervical and breast cancer early detection services in several low and middle income countries. Dr. Basu has 249 publications in peer-reviewed journals with more than 6500 citations.